AbbVie Inc. (ABBV)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:03PM EDT
After hours:
| Previous close | 152.34 |
| Open | 153.00 |
| Bid | 152.52 x 1000 |
| Ask | 153.42 x 1000 |
| Day's range | 152.75 - 155.45 |
| 52-week range | 105.56 - 175.91 |
| Volume | |
| Avg. volume | 7,338,458 |
| Market cap | 270.615B |
| Beta (5Y monthly) | 0.81 |
| PE ratio (TTM) | 21.97 |
| EPS (TTM) | 6.97 |
| Earnings date | 28 July 2022 - 01 Aug 2022 |
| Forward dividend & yield | 5.64 (4.08%) |
| Ex-dividend date | 14 Apr 2022 |
| 1y target est | 163.01 |
- Zacks
AbbVie's (ABBV) Rinvoq Gets CHMP Nod for New Indication
The CHMP recommends approval of AbbVie's (ABBV) Rinvoq for treating adults with active non-radiographic axial spondyloarthritis.
- PR Newswire
Approximately 15,000 AbbVie Employees to Volunteer Globally to Support Local Communities in Annual Week of Possibilities
AbbVie kicks off its seventh Week of Possibilities today with approximately 15,000 employees volunteering in more than 50 countries to serve local communities around the world. From June 27 to July 1, AbbVie employees will work with trusted community partners to complete hands-on projects, including renovating schools, playgrounds and community centers, to benefit local communities impacting tens of thousands of people.
- Motley Fool
Is AbbVie About To Get A New Blockbuster Drug?
AbbVie recently applied for FDA approval of its advanced Parkinson's disease drug candidate. This could be huge considering it's set to lose market exclusivity of Humira.
© 2022 Yahoo. All rights reserved.
